Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "70.41",
    "chg": -1.39,
    "chgp": "-1.94%",
    "dir": -1,
    "prev_price": "71.80",
    "mcapval": "113.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083D01012",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "57.09 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3783128",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BalPharmaLtd_mojoScore_3783128.png",
        "date": "2026-01-06 10:10:26",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs.67.15 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-of-rs6715-amidst-continued-underperformance-3775264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharmaLtd_priceRelatedfactors_3775264.png",
        "date": "2025-12-30 16:01:18",
        "description": "Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 on 30 Dec 2025, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a sustained period of underperformance relative to the broader market and sector benchmarks."
      },
      {
        "title": "Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.67.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-stock-falls-to-52-week-low-of-rs6715-3773231",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharmaLtd_priceRelatedfactors_3773231.png",
        "date": "2025-12-29 10:28:49",
        "description": "Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and sector-wide challenges."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3769811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharmaLtd_mojoScore_3769811.png",
        "date": "2025-12-25 15:12:28",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Bal Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bal-pharma-fallingrising-3752158",
        "imagepath": "",
        "date": "2025-12-09 00:31:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Bal Pharma’s shares have been under pressure for several weeks, with the stock registering a 5.60% loss over the past week compared to a modest 0.63% decline in the Sensex. The one-month performance paints a starker picture, with the stock falling 14.02% while the Sensex gained 2.27%. Year-to-date, the stock has plummeted 42.41%, in sharp contrast to the Sensex’s 8.91% rise. Over the last year, the stock’s decline of 43.41% stands in opposition to the Sensex’s 4.15% gain, highlighting a significant divergence from broader market trends.</p>\n<p>Even over a three-year horizon, Bal Pharma has lost 21.43%, whereas the Sensex has surged 36.01%. Although the stock has posted a positive 17.53% return over five years, this pales in comparison ..."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.70.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs702-amidst-continued-downtrend-3751718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_priceRelatedfactors_3751718.png",
        "date": "2025-12-08 15:26:08",
        "description": "Bal Pharma has reached a new 52-week low of Rs.70.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have underperformed both its sector and the broader market, reflecting ongoing pressures on its financial performance and valuation metrics."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.70.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs702-amidst-weak-financial-metrics-3751720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_priceRelatedfactors_3751720.png",
        "date": "2025-12-08 15:25:53",
        "description": "Bal Pharma's shares reached a fresh 52-week low of Rs.70.2 today, marking a significant decline amid ongoing downward momentum. The stock has recorded losses over the past two sessions, reflecting persistent pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bal Pharma’s Market Assessment Revised Amidst Challenging Financial and Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3748258",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_mojoScore_3748258.png",
        "date": "2025-12-05 10:10:27",
        "description": "Bal Pharma has experienced a revision in its market evaluation, reflecting a more cautious outlook driven by recent financial results, valuation considerations, and technical trends. This shift highlights the complexities facing the pharmaceutical company amid ongoing sector challenges and market pressures."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.73.04 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs7304-amidst-continued-underperformance-3748383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_priceRelatedfactors_3748383.png",
        "date": "2025-12-05 09:53:08",
        "description": "Bal Pharma’s shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock declined by 2.05% during the trading session, underperforming its sector peers and continuing a trend of subdued market performance over the past year."
      }
    ],
    "total": 115,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Jan-2026",
      "details": "We are submitting newspaper advertisements of the postal ballot notice issued by the Company on 08.01.2026 and published on 09.01.2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jan-2026",
      "details": "Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.12.2025.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "08-Jan-2026",
      "details": "Postal Ballot notice for appointment of Dr.Mukesh Beekamchand ( DIN # 11295580) as independent Director of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd is Rated Strong Sell

2026-01-06 10:10:26

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bal Pharma Ltd Falls to 52-Week Low of Rs.67.15 Amidst Continued Underperformance

2025-12-30 16:01:18

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 on 30 Dec 2025, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a sustained period of underperformance relative to the broader market and sector benchmarks.

Read full news article

Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.67.15

2025-12-29 10:28:49

Bal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.67.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid subdued financial performance and sector-wide challenges.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2025-12-25 15:12:28

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Why is Bal Pharma falling/rising?

2025-12-09 00:31:10

Recent Price Movement and Market Context

Bal Pharma’s shares have been under pressure for several weeks, with the stock registering a 5.60% loss over the past week compared to a modest 0.63% decline in the Sensex. The one-month performance paints a starker picture, with the stock falling 14.02% while the Sensex gained 2.27%. Year-to-date, the stock has plummeted 42.41%, in sharp contrast to the Sensex’s 8.91% rise. Over the last year, the stock’s decline of 43.41% stands in opposition to the Sensex’s 4.15% gain, highlighting a significant divergence from broader market trends.

Even over a three-year horizon, Bal Pharma has lost 21.43%, whereas the Sensex has surged 36.01%. Although the stock has posted a positive 17.53% return over five years, this pales in comparison ...

Read full news article

Bal Pharma Stock Falls to 52-Week Low of Rs.70.2 Amidst Continued Downtrend

2025-12-08 15:26:08

Bal Pharma has reached a new 52-week low of Rs.70.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have underperformed both its sector and the broader market, reflecting ongoing pressures on its financial performance and valuation metrics.

Read full news article

Bal Pharma Stock Falls to 52-Week Low of Rs.70.2 Amidst Continued Downtrend

2025-12-08 15:25:53

Bal Pharma's shares reached a fresh 52-week low of Rs.70.2 today, marking a significant decline amid ongoing downward momentum. The stock has recorded losses over the past two sessions, reflecting persistent pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Bal Pharma’s Market Assessment Revised Amidst Challenging Financial and Technical Indicators

2025-12-05 10:10:27

Bal Pharma has experienced a revision in its market evaluation, reflecting a more cautious outlook driven by recent financial results, valuation considerations, and technical trends. This shift highlights the complexities facing the pharmaceutical company amid ongoing sector challenges and market pressures.

Read full news article

Bal Pharma Stock Falls to 52-Week Low of Rs.73.04 Amidst Prolonged Downtrend

2025-12-05 09:53:08

Bal Pharma’s shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock declined by 2.05% during the trading session, underperforming its sector peers and continuing a trend of subdued market performance over the past year.

Read full news article

View All News